New therapeutic studies and meta-analyses: St John's wort extracts versus synthetics;Neue therapiestudien und metaanalysen: Johanniskrautextrakte vs. synthetika

Pharmazie in Unserer Zeit

Volumn 32, Issue 3, 2003, Pages 228-234

  Schulz, Volker ^a  

^a Oranienburger Chaussee 25   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BROMAZEPAM; FLUOXETINE; HYPERICUM PERFORATUM EXTRACT; IMIPRAMINE; MAPROTILINE; PLACEBO; SERTRALINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG INDICATION; HUMAN; MEDICAL PRACTICE; META ANALYSIS; OUTCOMES RESEARCH; PHARMACODYNAMICS; RATING SCALE; TREATMENT OUTCOME;

EID: 0038295936     PISSN: 00483664     EISSN: None     Source Type: Journal    
DOI: 10.1002/pauz.200390069     Document Type: Article

References (16)

1. Anonymus (2001) Note for guidance on clinical investigation of medicinal products in the treatment of depression. The European Agency for the Evaluation of Medicinal Products: CPMP/EWP/518/97 rev 1 draft. EMEA 2001.
2. Anonymus: Nutzen und Risiken von Johanniskraut. arznei-telegramm (2000) 31: 15.
3. Brenner, R., Azbel, V., Madhusoodanan, S., Pawlowska, M.: Comparison of extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study. Clin Therap 22 (2000): 411-419.
4. Gensthaler, BM.: Johanniskraut ist Placebo überlegen. Pharm Ztg (2001) 146 Nr. 24 (Vorläufige Mitteilung vom 24.06.01).
5. Hamilton, M.: A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960): 56-61.
6. Hypericum Depression Trial Study Group: Effect of Hypericum perforatum (St. John's Wort) in Major Depressive Disorder. A Randomized Controlled Trial. JAMA 287 (2002): 1807-1814.
7. Kirsch, I., Sapirstein, G. (1998): Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention & Treatment, 1, Article 0002a. Available on the World Wide Web: http://journals.apa.org/prevention/volume1/pre0010002a.html.
8. Lecrubier, Y., Clerc, G., Didi, R., Kieser, M.: Efficacy of St. John's Wort WS 5570 in major depression: A double-blind, placebo-controlled trial. Am J Psychiatry 159 (2002): 1361-1366.
9. Malt, U.F., Robak, O.H., Madsbu, H.P., Bakke, O., Loeb, M.: The Norwegian naturalistic treatment study of depression in general practice (NORDEP)-I: Randomised double blind study. BMJ 318 (1999): 1180-1184.
10. Mulrow, C.D., Williams, J.W., Trivendi, M. (1999): Treatment of depression: newer pharmacotherapies. AHCPR publication no. 99-E014. http://www.ahcpr.gov/clinic/deprsumm.htm.
11. Philipp, M., Kohnen, R., Hiller, K.O.: Hypericum extract versus imipramine or placebo in patients with moderate depression: Randomized multicentre study of treatment for eight weeks. BMJ 319 (1999): 1534-1539.
12. Schulz, V. (1999) Stellenwert von Hypericum-Extrakten in der Therapie leichter bis mittelschwerer Depressionen. In: Loew, D., Blume, H., Dingermann, T. (Hrsg.) Phytopharmaka V - Forschung und klinische Anwendung. Steinkopff-Verlag, Darmstadt, pp. 151-156.
13. Schulz, V.: The psychodynamic and pharmacodynamic effects of drugs: A differenciated evaluation of the efficacy of phytotherapy. Phytomed 7 (2000): 73-81.
14. Schulz, V.: Incidence and clinical relevance of the interactions and side effects of Hypericum preparations. Phytomed 8 (2001): 152-160.
15. Shelton, C.R., Keller, M.B., Gelenberg, A. et al.: Effectiveness of St. John's Wort in major depression: a randomized controlled trial. JAMA 285 (2001): 1978-1985.
16. Wheatley, D.: LI 160, an Extract of St. John's Wort, Versus Amitriptyline in Mildly to Moderately Depressed Outpatients - a Controlled 6-Week Clinical Trial. Pharmacopsychiatry 30 (Suppl, 1997): 77-80.